Skip to main content
. Author manuscript; available in PMC: 2018 Feb 27.
Published in final edited form as: Clin Rev Allergy Immunol. 2017 Feb;52(1):1–19. doi: 10.1007/s12016-015-8510-y

Table 1.

Myositis-specific and myositis-associated autoantibodies

Type of autoantibodies Myositis-specific antibodies (MSA) Myositis-associated antibodies (MAA) Other autoantibodies often found in myositis
Autoantibody specificities Classic MSA: Jo-1, PL-7, PL-12, EJ, OJ, Mi-2, SRP
New antibodies that can be considered MSA: KS, TIF1γ/α, TIF1β, MJ/NXP-2, MDA5/CADM-140, SAE
PM-Scl, Ku, U1RNP, U1/U2RNP, U3RNP Ro52, Ro60, Su/Ago2
Association with SARD PM/DM, PM/DM-overlap syndrome PM/DM, PM/DM-overlap syndrome, SSc, SLE Various SARD
Detection in non-PM/DM Uncommon (anti-ARS can be in overlap syndrome and idiopathic ILD) Not uncommon Often
Association with myopathy when found in non-PM/DM Yes Yes No or not established
Prevalence In general population [20] Almost none PM-Scl, Ku, U1/U2RNP—almost none; U1RNP, ~0.1 % Relatively common (0.5–1 %)

SARD systemic autoimmune rheumatic diseases, PM polymyositis, DM dermatomyositis, SSc scleroderma, systemic sclerosis, SLE systemic lupus erythematosus, ILD interstitial lung disease